| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |